Introduction
In multicellular organisms, vascular tissue is necessary to establish a circulation that delivers nutrients and oxygen, removes waste products, and provides a means for interorgan communication (Risau, 1997) . In animals, the vasculature is comprised of blood vessels, which permeate most tissues to ensure sufficient oxygen diffusion. Blood vessels are lined by a specialized cell type called endothelial cells, and, given their ubiquitous presence, it is not surprising that they have evolved functions beyond nutrient and oxygen transport. In recent years, significant progress has been made in describing the reciprocal relationship between the endothelial compartment and its surrounding microenvironment. It is now apparent that endothelial cells provide inductive signals during organ development as well as cell guidance molecules involved in patterning. Conversely, the vasculature responds to cues from the parenchyma that bestow upon it tissue-specific functions. Similar signals function under pathological conditions, where endothelial cells play a critical role in defining the local immune response and provide support for tumor growth. Given their vital importance to tissue survival, many of these mechanisms are being targeted in hopes of limiting tumor growth and ameliorating destructive inflammatory diseases. In this review, we discuss the major advances leading to the current understanding of how endothelial cell interactions may influence development and the adult state. We first focus on relevant advances in vasculogenesis/angiogenesis and the reciprocal signals that function during this process. Then, the mechanisms by which endothelial cells influence organogenesis are highlighted with a final discussion on their relation to pathophysiology, particularly tumorigenesis.
Vascular Morphogenesis
Formation of the cardiovascular system is one of the earliest events to occur during embryonic development. Much is known about the genetic requirements during this process, principally involving receptor tyrosine kinases and their ligands, including the following receptorligand pairs: VEGF-A/VEGFR-1 and -2, Ang1/Tie2, and ephrinB2/EphB4 (reviewed in Coultas et al., 2005; Ferrara and Kerbel, 2005) .
Vascular development begins when cells of mesenchymal origin within the embryo differentiate into multipotent angioblasts, which are believed to arise from the hemangioblast, a common precursor for endothelial and hematopoietic lineages. These cells undergo vasculogenesis where they aggregate and form a primitive vascular network de novo (Risau, 1997) . Subsequent signaling events stimulated by the surrounding environment, hemodynamic forces, and the endothelium itself trigger the complex process of vascular remodeling (reviewed in Carmeliet, 2003; Ferrara and Kerbel, 2005) . Extensive pruning, angiogenesis (outgrowth from preformed vessels), and investment with extravascular cell types results in the formation of a mature vessel network containing arterial, capillary, and venous components, each of which can be associated with different types and amounts of peri-vascular support cells as well as develop tissue-specific functions (Figure 1 ).
The morphogenic events that occur during vasculogenesis/angiogenesis are not thoroughly understood, but current efforts in zebrafish are shedding new light on the issue. As a result of multiple in vitro and genetic observations, hemangioblasts have been proposed to be the common precursor of hematopoietic and endothelial cell lineages (Eichmann et al., 2002) . However, formal proof of their existence in vivo has been lacking. Recent studies have provided evidence for the presence of hemangioblasts in vivo in zebrafish and reveal some surprising properties of these progenitors (Vogeli et al., 2006) . Lineagetracing experiments that labeled single cells at the ventral margin of the embryo at 1 hr post gastrulation could give rise to a labeled population consisting exclusively of hematopoietic (gata-1-positive) and endothelial (Flk1-positive) lineages. Surprisingly, the hemangioblasts labeled in these experiments did not contribute to all endothelial cells. Instead, they produced a population that clusters at specific regions of the axial vessels, which have been proposed to be involved in hematopoiesis (Vogeli et al., 2006) . The fact that hemangioblasts may generate only a specialized subset of vessels reveals a higher complexity of compartmentalization during vascular development.
Interactions between endothelial cells and their surrounding environment are critical for vascular maturation (Figure 2 ). One component of this environment is the extracellular matrix (ECM), a scaffold of proteins secreted and organized by cells including those of stromal and endothelial origin. Blood vessels are encased in a specialized sleeve of ECM called the basement membrane (BM), which provides structural support, serves as a substrate for endothelial cell migration, and regulates pro-and antiangiogenic factors (Gerhardt and Betsholtz, 2003) . The importance of this structure is underscored by the vascular defects seen in mice deficient in various BM constituents such as type IV collagen and laminins (Davis and Senger, 2005; Poschl et al., 2004; Thyboll et al., 2002) . Interestingly, the BM can be pro-and antiangiogenic, often using different cleavage products of the same protein (Gerhardt and Betsholtz, 2003) . For example, intact type IV collagen promotes endothelial proliferation and migration through integrin a1b1 and a2b1 binding, whereas degradation products bind avb3, inhibiting these same processes (Nyberg et al., 2005) . ECM cleavage can produce multiple antiangiogenic molecules that are detectable in the circulation, including arresten (a 26 kD fragment of the NCI domain of type IV collagen a1), canstatin (a 24 kD fragment of type IV collagen a2 chain), tumstatin (a 28 kD fragment of type IV collagen a3 chain), and endostatin (a 20-22 kD C-terminal fragment of the collagen type XVIII a1chain) (reviewed in Nyberg et al., 2005) . Mechanistically, tumstatin appears to be an endothelial-specific protein synthesis inhibitor that, upon binding avb3 integrin, inhibits focal adhesion kinase (FAK), phosphatidylinositol 3-kinase (PI3-kinase), protein kinase B (PKB/Akt), and mammalian target of rapamycin (mTOR), leading to downregulation of CAP-dependent protein translation (Maeshima et al., 2002) . The role of these molecules during development has not been well characterized, but evidence suggests that they may be important regulators in pathological conditions (see below).
To become stabilized and mature, vessels must recruit and associate with support cells, including mural cells (pericytes and vascular smooth muscle cells [vSMCs] ). These two cell types are morphologically similar and share the expression of several different markers, but differ in their relationship to the endothelial cell layer (Gerhardt and Betsholtz, 2003) . vSMCs cover larger vessels and have no direct contact with the endothelium, while pericytes support smaller vessels and cross through holes in the basement membrane to form tight and gap junctions with endothelial cells. One pericyte may interact with more than one endothelial cell (Simionescu and Simionescu, 1988) and is thus able to integrate signals along the length of the blood vessel.
As they mature, naked blood vessels attract pericytes and vSMCs through PDGF-B. Mice deficient in either PDGF-B (including an endothelial-specific conditional knockout) or PDGFR-b lack mural cell coverage, leading to endothelial hyperplasia, impaired endothelial differentiation, edema, hemorrhage, and lethality (Lindahl et al., 1997; Gerhardt and Betsholtz, 2003) . Interactions between PDGF-B and the ECM are essential. Vessels in mice that harbor a deletion in the PDGF-B retention motif, which is required for its association with the ECM, display defects in pericyte investment (Lindblom et al., 2003) . Metalloproteinases are also important, which, in the case of MMP-9, are predominately produced by stromal and bone marrow-derived cells. Vessels in mice lacking MMP-9 and MT1-MMP do not properly associate with mural cells, while MT1-MMP null vSMCs exhibit defects in PDGF-B responsiveness (Chantrain et al., 2004; Jodele et al., 2005; Lehti et al., 2005) . In addition to influencing mural cell migration, endothelial cell-derived signals also trigger their differentiation. This activity includes mechanisms that required heterotypic cell-cell interactions between the two populations and are partially dependent on TGFb (Ding et al., 2004; Hirschi et al., 2003) .
Reciprocal signals also occur where mural cells influence endothelial function. For example, mural cells can reinforce the angiogenic response by producing VEGF-A to stimulate endothelial growth (Reinmuth et al., 2001; Reynolds et al., 2000) . Conversely, pericytes are important The circulation is structured such that oxygenrich blood leaving the heart is delivered to different tissues through arterial vessels that are invested with a significant layer of vascular smooth muscle. Within the tissue, these vessels branch into smaller capillaries capable of mediating oxygen and nutrient exchange. Capillaries are primarily associated with pericytes and can develop tissue-specific characteristics. For example, constitutive VEGF expression in certain endocrine glands promotes a fenestrated (gapped) endothelial layer, while astrocyte-derived TGFb and Ang-1 induces tight junctions characteristic of the blood-brain barrier. Following exchange, capillaries converge, forming venous vessels that deliver deoxygenated blood back to the heart. In general, veins are lower resistance and have larger lumens than arteries, with a reduced amount of vascular smooth muscle coverage.
sources of restrictive signals, as evidenced by the presence of endothelial hyperplasia in PDGF-B and PDGFRb null mice (Hellstrom et al., 2001) . Pericytes, vSMCs, and the surrounding mesenchyme produce angiopoietin-1 (Ang-1), which binds the tyrosine kinase receptor, Tie2, expressed on endothelial cells, resulting in enhanced endothelial-mural cell interactions, possibly through the induction of hepatocyte growth factor (HGF) (Kobayashi et al., 2006; Sato et al., 1995; Suri et al., 1996) . A homolog, Ang-2, appears to antagonize Ang-1, at least in some settings, relaxing these interactions and triggering BM degradation in preparation for angiogenic cell migration (Maisonpierre et al., 1997) . Several other molecules, including VCAM, a4b1 integrin, and sphingosine-1-phosphate (SIP) and its receptor, SIP1, are involved in mural cell recruitment and/or vessel stabilization (von Tell et al., 2006) . Elaboration of the vessel structure during angiogenesis involves coordinated attractive and repulsive guidance cues. As this is similar to axon pathfinding during neural development, it is not surprising that guidance molecules are shared between the two systems, specifically the receptor-ligand pairs Eph/ephrin, semaphorin/neuropilin/ plexin, netrin/UNC, and Slit/Robo (Eichmann et al., 2005) . Further intertwining of these pathways occurs when VEGF-A uses the semaphorin receptor, neuropilin-1. Surprisingly, neuropilin-1 was found to be a coreceptor that selectively interacts with the heparin-binding VEGF isoforms and enhances the effectiveness of VEGFR2-mediated signaling (Soker et al., 1998) . A widely used system for studying vascular guidance mechanisms has been the angiogenesis that occurs within the developing somites. During embryonic development, vessels sprout from the dorsal aorta and grow dorsally in an intersomitic distribution. This pattern can be disrupted, causing ectopic vessel sprouting, by deletion of multiple repulsive cues expressed within the somites, including ephrinB molecules (Adams et al., 1999; Gerety et al., 1999; Helbling et al., 2000) and semaphorin3E Gu et al., 2005; Torres-Vazquez et al., 2004) . Disruption of the netrin1a/UNC5b axis similarly affects intersomitic sprouting . These observations, coupled with experiments showing tip cell or filapodia retraction upon treatment with these factors, establish their role as repulsive guidance molecules during angiogenesis.
A recent report attributes an attractive function to netrin1a during vascular remodeling, which was in an UNC5b-independent fashion (Wilson et al., 2006) . Also, netrin1 was found to stimulate angiogenesis in various in vivo models (Park et al., 2004) . In addition, application of netrin-1 or -4 increased vascular recovery in a model of hindlimb ischemia to levels at or above those stimulated by VEGF (Wilson et al., 2006) . These observations conflict with the above mentioned studies describing netrins as potential repulsive signals for the vasculature , although the basis of this discrepancy is not currently understood.
Developmental Signals that Direct Artery-Vein Specification Observations made by anatomists hundreds of years ago recognized that the arterial and venous sides of the circulation possess distinct morphological and physiological characteristics. For many years, it was thought that blood flow was responsible for establishing vascular identity, triggering the development of associated architectural specializations. This view was changed in the late 1990s when two groups showed that ephrinB2 and its receptor, EphB4, were cell surface markers of arteries and veins, respectively, and that they were expressed before the onset of blood flow (Adams et al., 1999; Wang et al., 1998) . These data demonstrated that arterial and venous specification in the developing embryo can be genetically predetermined. Additionally, interactions between arterial ephrinB2 and venous EphB4 are required for vascular development, since mice deficient in either molecule do not undergo angiogenesis. Review Subsequent studies in zebrafish and mice delineated the pathways upstream of ephrinB2 expression, particularly during dorsal aorta formation ( Figure 3 ). Sonic hedgehog derived from the notochord and floor plate induces VEGF expression in adjacent somitic tissue. VEGF-A upregulates Notch pathway components, including Notch-1 and its ligand, Delta-like-4, in nearby endothelial cells (Duarte et al., 2004; Lawson et al., 2001; Lawson et al., 2002) , which, in mice, occurs through the activity of the transcription factors Foxc1 and Foxc2 (Seo et al., 2006) . Localization of both Notch and Notch ligands in the endothelial cells themselves suggest a juxtacrine signaling mechanism, which eventually leads to the expression of the bHLH transcription factors gridlock (zebrafish) and hesr1/hesr2 (mice) (Kokubo et al., 2005; Zhong et al., 2001) . Animals missing any of the genes discussed above or both of the Notch effector genes, Hey1 and Hey2 (Fischer et al., 2004) , show defective ephrinB2 expression and arterial development while venous specification is generally unaffected. Strikingly, both copies of the Delta-like-4 gene are required; haploinsufficient mice display lethality due to arterial vascular abnormalities (Duarte et al., 2004; Gale et al., 2004; Krebs et al., 2004) . These and other experiments that alter Notch activity have emphasized the importance of vessel identity. Arteriovenous malformations develop when Notch signaling is either reduced (Krebs et al., 2004) or constitutively active (Carlson et al., 2005) in endothelial cells, likely a result of EphB4 or ephrinB2 misexpression leading to defective boundary formation.
Discovery of arterial specification pathways gave rise to the idea that venous development is the default state, while arteries arise in the presence of active signaling events. This idea was later challenged when COUP-TFII, an orphan nuclear receptor, was shown to be an active vein specification factor (You et al., 2005) . Genetic ablation of this molecule resulted in the arterialization of veins, and its ectopic expression could suppress Neuropilin-1 expression and Notch signaling usually active in arterial cells. Histology of the transformed veins noted the presence of hematopoietic clusters appearing to bud from the endothelial layer, a feature usually attributed to arterial vessels. In future experiments, it will be interesting to elucidate this pathway and determine its complexity in comparison to arterial differentiation.
Despite recent focus on the genetic programs that determine vessel identity, modern techniques have also been used to address the impact of blood flow on endothelial cell differentiation. Engraftment experiments have shown that avian vascular identity is reversible during the embryonic period, suggesting a role for the microenvironment (Moyon et al., 2001) . Time-lapse analysis reveals that this vascular plasticity is physiologically important during angiogenesis within the yolk sac vascular tree. As to laminar stress, eliminating blood flow in this tissue interrupted arterial differentiation, and its reversal transformed arteries into veins in terms of marker expression (le Noble et al., 2004). Thus, endothelial cells are plastic in some cases and can respond to shear stress cues to further refine their differentiation status.
Endothelial-Derived Signals Support Organ Development and Function
Given the ubiquitous presence of vascular networks and their importance in tissue survival, it is not surprising that they have acquired functions in addition to oxygen and nutrient transport (Figure 4) (Cleaver, 2004) . Close associations between vessels and developing organs have been observed for many years, suggesting the possibility that they can provide inductive signals. Testing such hypotheses is complicated by the fact that loss-of-function observations could be due to the interruption of blood flow. Several studies have circumvented this problem by making observations during development, before the onset of blood flow, as well as by utilizing in vitro methods. Heart Studies of heart development gave the first evidence of reciprocal interactions between endothelial and surrounding tissue during development. The myocardial layer fails to mature in the absence of endothelium (Stainier et al., 1995) . Endocardial cells produce neuregulin, which binds to ErbB2 and B4 on adjoining myocardium, inducing trabeculation of this cell layer, enabling heart contractility (Kramer et al., 1996; Meyer and Birchmeier, 1995) . Conversely, signals from the myocardium including TGFbeta (Brown et al., 1999; Dor et al., 2001 ) and VEGF (Dor et al., 2001 ) are required to induce the endothelial-mesenchymal transition of endocardial cells that precedes valve formation. 
Developmental Cell

Review
Interactions between Endothelial Cells and the Hematopoietic System In addition to sharing a common precursor, hematopoietic cells extensively interact with endothelial cells from the earliest embryonic stages onward. During development, hematopoietic colonies are localized first in extraembryonic yolk sac blood islands before appearing in the aorta-gonad-mesonephrous (AGM) region of the embryo and the placenta (Gekas et al., 2005; Ottersbach and Dzierzak, 2005) . At this time, hematopoietic cells appear to bud from aortic vessels, suggesting that endothelial cells support hematopoietic stem cell (HSC) genesis. Genetic labeling experiment confirmed that some cells with HSC activity, meaning the ability to completely reconstitute lethally irradiated recipients, can be derived from the endothelial cell layer (de Bruijn et al., 2002) . These newly born HSCs populate the fetal liver and eventually home to the bone marrow, which is the major site of hematopoiesis throughout adult life.
It has been proposed that, in the adult bone marrow, sinusoidal endothelial cells influence HSC function. Endothelial cells isolated from hematopoietic regions of the embryo have the ability to support HSCs in vitro Ohneda et al., 1998) . Furthermore, in situ localization using a novel HSC subtype marker, CD150, found that this cell population is located adjacent to the sinusoidal vasculature. These observations have prompted the recognition of a potential vascular niche, in addition to the well-described endosteal (bone) surface, as a microenvironment that supports stem cell activity (Kiel et al., 2005) . There is evidence that the vascular niche regulates other progenitor populations. In vitro, bone marrow endothelial cells boost the survival and maturation of megakaryocytes in a contact-dependent manner. In addition, the residual thrombopoiesis detected in thrombopoietindeficient mice is greatly enhanced by the administration of CXCL12 (SDF-1) and FGF4, a treatment that functions by localizing megakaryocytes to the vascular niche (Avecilla et al., 2004 ).
The close relationship between endothelial and hematopoietic cells is further supported by cell lineage studies. Derivation of hematopoietic cells from murine embryonic stem cells may include an intermediate hemangioblastic stage (Kennedy et al., 1997) , while human HSCs can incorporate into the vasculature of most murine tissues, with the exception of brain (Bailey et al., 2004) . In a quail-chick parabiosis model, HSCs were able to generate several nonhematopoietic cell types, including endothelial cells, smooth muscle, and adventitial tissues . Adult murine bone marrow-derived stem cells can also contribute to choroidal neovascularization. In this model, HSC differentiation was not the result of cell fusion, but rather a result of their ability to adopt an endothelial fate (Sengupta et al., 2003) . The two cell types also share regulatory mechanisms, as cytokines and growth factors involved in the maintenance/differentiation of hematopoietic lineages also affect endothelial cells. For example, granulocyte macrophage colony stimulating factor (GM-CSF), a cytokine that drives HSCs and progenitor cell differentiation, induces angiogenesis in a chick chorioallantoic membrane (CAM) assay through activation of the Jak2/Stat3 pathway (Valdembri et al., 2002) . In total, current evidence suggests that endothelial cells and hematopoietic cells functionally complement each other during both embryonic and adult life. Induction of Endoderm-Derived Tissues Liver development begins when a portion of the ventral foregut endoderm is specified as hepatocyte primordium, exhibiting a columnar epithelial appearance at e8.5 (Zaret, 2002) . This region lies adjacent to primitive endothelial cells that express VEGFR2, located within the septum transversum mesenchyme. As development progresses following e9.5, the endodermal epithelial cells divide and invade the mesenchyme, intermixing with resident endothelial cells and their associated hematopoietic colonies. Using mice genetically deficient in endothelial cell lineages (flk-1-deficient), it was established that endothelial cell-derived signals promote hepatic endoderm budding independent of blood flow (Matsumoto et al., 2001) . In these mice, hepatic endoderm within the liver bud proliferated, but the cells never expanded into the adjacent tissue. In vitro explants of the e9.5 liver bud from wild-type mice formed a vascular network and supported growth of albumin-positive cells after 72 hr in culture. Hepatic outgrowth was severely blunted in the absence of endothelial cells in explants from either flk-1 mice or those treated with an inhibitor of angiogenesis.
The endothelial-derived signals leading to hepatocyte differentiation and migration have not been identified. Clues may come from experiments performed in adult tissues, where VEGF-A increases hepatocyte growth by stimulating the sinusoidal endothelium to produce HGF (LeCouter et al., 2003c) . This activity reduced liver damage in mice exposed to a hepatotoxin. Thus, endothelialderived HGF is a candidate regulator of liver organogenesis in the developing embryo.
The thyroid also appears to respond to arterial vascular cues during development independent of blood flow. However, instead of regulating early budding from the pharyngeal epithelium, endothelial cells control positioning of the thyroid primordium during developmental relocalization. The thyroid was misplaced in both zebrafish and mouse mutants with defective vessel development. In addition, ectopic localization of endothelial cells influenced thyroid localization. Identifying nearby vessels suggested a mechanism by which arterial vessels, or an associated cell type, produce attractive guidance signals that act on the thyroid primordial organ (Alt et al., 2006) .
The pancreas is another endodermal tissue that develops in close apposition to blood vessels (Field et al., 2003a; Lammert et al., 2001; Pictet et al., 1972) . Isolated murine dorsal endoderm only gives rise to insulin secreting cells in culture when aortic explants are present (Lammert et al., 2001 ). In addition, dissection of the dorsal aorta from Xenopus embryos abolishes the expression of the pancreatic-specific genes NeuroD, Pax6, and insulin (Lammert et al., 2001 ). Conversely, hypervascularization through ectopic VEGF expression in this region leads to excess pancreatic tissue and ectopic insulin expression. Using flk-1 À/À mice that lack endothelial cells, Yoshitomi and Zaret corroborated these findings and showed that vascular cells have distinct interactions with dorsal and ventral pancreatic buds. In the absence of endothelial cells, the dorsal endoderm expresses Pdx1, a pancreatic specification transcription factor, but fails to induce the transcription factor Ptf1a (Yoshitomi and Zaret, 2004) . Interestingly, Ptf1a induction was normal in the ventral pancreatic buds of flk-1 À/À mice, although expression of glucagon was still affected. These differences may be due to the fact that the dorsal mesoderm is adjacent to arterial vessels while the ventral bud develops near veins. It will be interesting to determine whether the two vascular compartments produce factors that differentially affect organ development.
The presence of isl-1-positive mesenchymal tissue is also required for pancreatic specification and morphogenesis (Ahlgren et al., 1997), potentially through an FGF10-dependent mechanism (Jacquemin et al., 2006) . In fact, coculture experiments and analysis of flk-1 À/À mice demonstrate that growth and survival of the mesechyme itself (and consequently pancreatic development) depends on the presence of the dorsal aorta (Jacquemin et al., 2006) . Thus, vascular cells also participate in pancreatic development indirectly through ensuring stromal survival. At later stages in development, one report assigns a circulation-dependent effect of the vasculature on dorsal pancreatic mesenchyme. N-cadherin-deficient mice display defects in pancreatic budding that can be rescued by restoring blood flow by expressing the gene specifically in heart tissue (Esni et al., 2001) . Blood flow provides a source of sphingosine-1-phosphates that are required for dorsal mesenchyme survival and proliferation and, therefore, necessary for pancreatic budding (Edsbagge et al., 2005) .
Endothelial cells may also support pancreatic function in the adult. Within islets, the vasculature is the only source of the extracellular matrix proteins laminin a4 and a5 and collagen IV a1 and a2. In vitro, beta cell insulin production was increased in the presence of these ECM proteins. In addition, insulin production in mice is decreased when islet vascular density is reduced through pancreaticspecific ablation of VEGF-A (Nikolova et al., 2006) . Thus, vascular-derived ECM proteins may function in the maintenance of particular islet cell functions. Taken together, current evidence supports a model in which the vasculature is involved in pancreatic development and maintenance at multiple stages involving interactions with multiple important tissue types with aspects dependent and independent of blood flow.
Given the different model systems utilized for studying developmental biology including zebrafish, chicks, Xenopus, and mice, one should use caution in extrapolating information across species. For example, zebrafish containing the cloche mutation lack endothelial cells, but liver and pancreas development appears to proceed normally (Field et al., 2003a (Field et al., , 2003b , contrasting with the information reported in other species. However, cloche mutants show similar requirements for endothelial cells in the kidney. These mutants lack proper maintenance of podocyte function within the glomerulus (Majumdar and Drummond, 1999) . Similarly, recession of glomerular capillaries through deletion of one VEGF-A allele within podocytes is coincident with the effacement of podocyte foot processes (Eremina et al., 2003) .
Endothelial Cells and Neural Tissue
In addition to acquiring vascularization, many tissues must also become innervated to function properly. To permeate tissues, neurons and blood vessels share the strategy of forming branching networks, and, in some locations, the two cell types migrate along strikingly similar paths (reviewed in Carmeliet and Tessier-Lavigne, 2005) . There is evidence that this results from reciprocal chemotactic signals between the two tissue types. During development, vascular smooth muscle cells produce Artemin and neurotrophin-3, which attract sympathetic neuron migration, resulting in the close spatial relationship between the two cell types (Honma et al., 2002; Kuruvilla et al., 2004) . Conversely, vessels in the skin follow resident sensory nerves even when the neurons are off track, and, in their absence, fail to undergo arterial differentiation (Mukouyama et al., 2002) . In this location, neurons produce VEGF, which may function to attract endothelial cells. Neuron-derived VEGF is required for arterialization of neighboring vessels in a feedback loop that requires endothelial expression of neuropilin-1 (Mukouyama et al., 2005) .
In the central nervous system, endothelial cells may be important modulators of stem cell activity. Anatomical observations have placed neural stem cells in close apposition to the endothelium, prompting speculation of a cooperative interaction. Coculture experiments demonstrated that endothelial cells dramatically affected the composition of embryonic neural stem cell cultures (Shen et al., 2004) . The presence of endothelium increased stem cell self-renewal through a Notch and Hes1 pathway (Shen et al., 2004) . Interestingly, upon removal of the endothelial cells, neuron differentiation was increased when compared to monoculture controls. In the songbird brain, studies point to a role for the endothelium in stimulating the neural recruitment that leads to seasonal expansion of the higher vocal center in canaries. In the adult forebrain, testosterone initiates a signaling loop that upregulates VEGF expression, ultimately stimulating local angiogenesis. The newly formed vessels increase BDNF production, stimulating the migration of neurons located within the ventricular zone (Louissaint et al., 2002) . The result is a gonadal hormone-regulated system where the vasculature is intimately involved in modulating seasonal avian behavior.
Tissue-Specific Signals Specialize Different Vascular Beds
As different organs have specific needs in terms of nutrient requirements and transport, the vasculature can take on a variety of unique phenotypes. Microarray analyses demonstrate that endothelial cells from different tissue sources vary at the transcriptional level (Chi et al., 2003) . In transplantation studies, tissue-specific gene expression in endothelial cells was found to be induced by the organ microenvironment (Aird et al., 1997) . In vivo screening of phage-displayed peptide libraries has shown considerable differences among blood vessels of different organs, both in normal and pathological circumstances (Ruoslahti, 2004) . A proteome-based approach has identified tissuespecific patterns of endothelial cell surface proteins (Oh et al., 2004) , raising the possibility that such diversity may be exploited therapeutically or diagnostically.
Common morphological differences among the endothelia of different vascular beds include cell size and shape, extent of mural cell coverage, and capillary bed permeability (Simionescu and Simionescu, 1988) . For example, endocrine organs such as the adrenal gland, pituitary, and pancreas often have fenestrated capillaries that contain pores sometimes lined with thin diaphragms. These structures are thought to allow increased transport of long-range hormones between extravascular cells and blood (Simionescu and Simionescu, 1988) . In fact, eliminating fenestrations in pancreatic islets diminishes the ability of mice to mount a wild-type response to glucose challenge, although glucose regulation is not completely lost (Brissova et al., 2006; Lammert et al., 2003) . Additionally, a loss of fenestrations in the liver is associated with faulty lipid uptake (Carpenter et al., 2005 ).
VEGF appears to be an important regulator of vascular fenestrations. Inhibitors of VEGF signaling pathways decrease the presence of fenestrated endothelium in multiple organs, including pancreatic islets and the kidney (Gerber et al., 1999; Kamba et al., 2006) . Ectopic expression of VEGF induces their presence in vessels that are not normally fenestrated (Roberts and Palade, 1995) . In fact, early observations noted persistent expression of VEGF in adult tissues only in epithelial cells associated with fenestrated vessels (Breier et al., 1992) . As to the mechanism, VEGF signaling may contribute to a fenestrated phenotype by stimulating internalization of the cell-cell adhesion molecule, VE-cadherin (Gavard and Gutkind, 2006) .
In contrast to the fenestrated vascular beds present in high-transport organs, capillaries that directly contact neural and ocular tissue are linked by extensive tight junctions that restrict transendothelial movement. Accordingly, the cells express increased levels of regulatory transporters, for example, GLUT-1, LAT-1, and EAAT1-3. This phenotype is thought to protect against potentially harmful effects, and, in the brain, it is referred to as the blood-brain barrier (Abbott et al., 2006) . Many studies have focused on the cell types within the central nervous system that regulate this barrier. Experiments, primarily in vitro models, assign functions to astrocytes, neurons, and pericytes. Currently, much of the evidence involves astrocytes, which develop perivascular endfeet that wrap the neural microvasculature. This cell type can induce the blood-brain barrier phenotype via TGFb (Tran et al., 1999) and angiopoetin-1 (Lee et al., 2003) secretion. Microarray analysis of PDGF-B and PDGFR-b null mice demonstrate that vascular pericytes also acquire tissuespecific qualities. Pericytes located in the brain, but not in the skin and heart, express specific markers including the ion channel Kir6.1 (Bondjers et al., 2006) .
Perhaps the most dramatically specialized vascular bed is that located in the uterus of placental mammals during pregnancy (Red-Horse et al., 2004) . In animals that exhibit hemochorial placentation (humans, rodents), fetal trophoblast cells from the placenta invade the maternal vasculature and replace the endothelial cell layer in a process called pseudovasculogenesis. The result is a network of hybrid vessels that funnel blood to and from the placental space, incorporating it into the uterine circulation for the purpose of maternal-fetal exchange. In humans, trophoblast invasion transforms maternal arterioles into largebore, low-resistance vessels, expanding lumen size up to 1000-fold and vastly increasing blood flow. This vascular remodeling requires that the cells undergo an epithelial-to-endothelial transition upregulating integrin avb3, vascular endothelial (VE)-cadherin, (Zhou et al., 1997a (Zhou et al., , 1997b , and ephrinB2, the latter of which explains these cells' tropism for arterioles rather than veins (Red-Horse et al., 2005) . In addition, trophoblasts induce a massive lymphangiogenic response in the endometrium, a tissue that normally lacks lymphatic vessels (Red-Horse et al., 2006) . When invasion is not carried out properly, trophoblasts are thought to be the source of factors that negatively influence the maternal vasculature systemically, which can result in the development of preeclampsia (Bdolah et al., 2004) . This potentially fatal pregnancy complication presents as a rapid onset of maternal hypertension, proteinuria, and edema and is associated with excess placental production of the soluble form of VEGFR-1 or sFlt-1 (Levine et al., 2004; Maynard et al., 2003) and endoglin (Venkatesha et al., 2006) .
Given the heterogeneity of vascular beds throughout different organ systems, there have been efforts to identify tissue-specific angiogenic molecules that function in regulating local vascular responses. Endocrine gland-vascular endothelial growth factor (EG-VEGF) is one such molecule, which has VEGF-like activities, but is structurally unrelated and signals through G protein-coupled receptors rather than tyrosine kinases (LeCouter et al., 2001; Lin et al., 2002) . EG-VEGF was identified for its ability to stimulate proliferation and migration in endothelial cells isolated from the adrenal and pancreas, but not those from other nonendocrine organs. In vivo, EG-VEGF elicited an appreciable angiogenic response in the mouse ovary, but not the eye, skeletal muscle, or ear (LeCouter et al., 2001 ). EG-VEGF mRNA was confined to endocrine organs in human tissues; however, investigation of its expression pattern in mice revealed a divergence between the two species. The murine homolog of EG-VEGF was highly expressed in the liver and kidney, while its receptors were detected in endothelial cells of the same organs (LeCouter et al., 2003a) . Thus, in mice EG-VEGF may regulate tissue-specific vascular biology in nonendocrine organs. Instead, its homolog, Bv8, (also known as prokineticin-2), was expressed at high level in the testis, and ectopic application stimulated testicular angiogenesis (LeCouter et al., 2003b) . It will be interesting to discover if other tissue-specific factors exist and whether or how they might compliment the VEGF pathway.
In addition to regulating vascular function, there is evidence that avascular tissues play an active role in excluding vessel ingrowth. The most well-characterized of these regions is the cornea, where in almost all species there is a complete absence of vascularization. Multiple antiangiogenic molecules have been localized to the corneal epithelium (Chang et al., 2001) ; however, only sFlt-1 appears to be required to maintain the avascular state. Genetic ablation of the receptor lead to corneal neovascularization, and sFlt-1 treatment reversed the spontaneous corneal vascularization that occurs in corn1 and Pax6 +/À mouse lines. These data present a physiological role for the soluble VEGF receptor, which appears to function through blocking VEGF activity (Ambati et al., 2006) .
Endothelial Signals and Tumor Growth
Disease states are frequently accompanied by dynamic changes in the vascular compartment. Endothelial cells are important first responders to inflammatory insults by attracting the infiltration of bone marrow-derived cells (Rosen, 2004) . Conversely, leukocytes within inflamed tissue can be powerful angiogenic stimulators. Given this positive feedback loop, regulatory mechanisms must be in place, which are unbalanced in situations of chronic inflammation (Carmeliet, 2003) . Research aimed at treating cancer through targeting the vasculature has helped increase our understanding of the interactions between the different cell types within the tumor environment and how these relationships impact vascular growth and homeostasis ( Figure 5 ).
Stromal Cells Influence Tumor Angiogenesis
The tumor environment is established following the onset of disregulated cell proliferation. A growing mass of neoplastic cells becomes embedded within the adjacent stroma consisting of a heterogeneous combination of fibroblasts, pericytes, and endothelial and hematopoietic cells, which can make up as much as 90% of the tumor mass (Weinberg, 2006) . Significant progress has been made in defining how nontransformed cells influence tumor initiation and growth, including their role during angiogenesis. Cells of hematopoietic lineage heavily influence the tumor vascular compartment in large part by secreting angiogenic molecules. Tumor-infiltrating T or B lymphocytes express significant amounts of VEGF-A (reviewed in Ferrara, 2004) . In a model of HPV16-initiated squamous cell carcinoma, mast cells (tissue basophils) contribute to the angiogenic switch that precedes carcinogenesis by producing molecules such as MMP-9 and the serine proteases MCP-4 and MCP-6 (Coussens et al., 1999 (Coussens et al., , 2000 . Neutrophils have been identified as another major source of MMP-9 and have a similar activity in a mouse model of pancreatic islet carcinogenesis (Nozawa et al., 2006) . A bulk of work from many laboratories has established that, in multiple cancer models, inhibiting tumorassociated macrophages decreases tumor growth and metastasis. Contributing to this effect is their production of angiogenic factors including VEGF-A, TNF-a, IL-8, bFGF, and MMP-9. These data agree with the observation that, in human pathological samples, poor prognosis is often correlated with a higher number of infiltrating macrophages (Lewis and Pollard, 2006) .
It has also been proposed that tumor-associated macrophages may differentiate into endothelial cells (Yang et al., 2004) . Coinjection of CD11b+Gr1+ myeloid spleen cells isolated from tumor-bearing mice boosts tumor growth and angiogenesis by secreting MMP-9, which stimulates VEGF release. In these experiments, the authors noted the incorporation of donor cells into the vasculature and that they had the capacity to differentiate into an endothelial cell phenotype ex vivo. It should be noted, however, that the contribution of bone marrow-derived cells to the endothelium remains quite controversial. Earlier studies proposed that circulating endothelial progenitor cells (EPC) may be incorporated into the growing vessel wall in various pathophysiological conditions (Asahara et al., 1997; Lyden et al., 2001 
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Review (De Palma et al., 2005; Grunewald et al., 2006) concluded that the percentage of EPCs that are truly incorporated into a growing vessel wall is low and that the majority of bone marrow-derived cells homing to the tumor vasculature are adherent perivascular mononuclear cells, which may locally produce angiogenic factors (reviewed in Ferrara and Kerbel, 2005) .
In addition to hematopoietic cells, fibroblasts can also contribute to tumorigenesis by producing angiogenic factors. In VEGF null fibrosarcoma xenografts, fibroblastderived VEGF-A promotes tumor angiogenesis and progression. In this model, the tumor cells recruited stromal fibroblasts via PDGF-A production (Dong et al., 2004) . Also highlighting the influence of the stroma, Liang et al. showed that blocking tumor cell-derived VEGF using human-specific VEGF-neutralizing antibodies is not as effective as cross-species antibodies in suppressing tumors that contain fibroblast dense stroma, such as the pancreatic cancer cell line HPAC . In vivo recombination experiments demonstrate that cancer-associated, but not normal, fibroblasts can promote epithelial tumor progression. The authors present data suggesting that CXCL12 contributes to this tumor-enhancing activity by recruiting EPCs from the blood that participate in vessel formation, in addition to stimulating tumor cell proliferation directly (Orimo et al., 2005) . ECM Components Modulate the Tumor Vasculature Endogenous antiangiogenic factors (see above) derived from the ECM, including endostatin, tumstatin and canstatin, have been reported to limit tumor growth in various animal models (reviewed in Nyberg et al., 2005) . Tumor angiogenesis and progression are reported to be elevated in mice that lack tumstatin due to inactivation of the type IV collagen a3 chain. Tumstatin administration reverses this effect without affecting normal angiogenesis, a result that requires the presence of b3 integrins (Hamano et al., 2003) . The authors implicate MMP-9 as the major proteinase responsible for cleaving type IV collagen, because mice lacking this protein exhibit decreased levels of circulating tumstatin accompanied by increased tumor growth (Hamano et al., 2003) . Interestingly, ECM regulation has been linked to the critical tumor suppressor, p53. This protein induces transcription of the matrix synthesizing enzyme, alpha(II) collagen prolyl-4-hydroxylase, which leads to the generation of tumstatin and endostatin. Conditioned media from p53 or alpha(II) prolyl hydroxylaseexpressing cells inhibits endothelial cell growth in vitro while expression of the latter molecule in tumor cells suppresses xenograft tumor expansion (Teodoro et al., 2006) . Thrombospondin-1 (TSP-1) is another angiostatic ECM component. Xenograft studies in TSP-1-deficient mice revealed increased tumor growth due to increased cell proliferation and vascular density as well as decreased apoptosis . TSP-1 regulates MMP-9; its overexpression decreases this molecule while the opposite effect is observed upon its deletion (RodriguezManzaneque et al., 2001) . Tumor-Associated Endothelial Cells Signal to Tumor Cells While a plethora of studies have elucidated the proangiogenic activities of tumor cells, fibroblasts, and inflammatory cells, relatively little is known about how endothelial cells affect this environment in a nutrient-independent manner. Endothelial cells within tumors have unique gene expression profiles, suggesting that they possess tissue-specific qualities (St Croix et al., 2000) . In a recent publication, Bandyopadhyay et al. provide evidence that endothelial cells can modulate metastasis through the cell-surface expression of DARC, a molecule previously Solid lesions consist of tumor cells enmeshed with various stromal types, which can include fibroblasts and hematopoietic and endothelial cells. These components communicate with each other and distant tissues (i.e., bone marrow) to affect the state of the vasculature and, as a consequence, tumor growth. Examples of angiogenic interactions are depicted in the figure. Cancer-associated fibroblasts produce CXCL12, which recruits bone marrow-derived endothelial progenitor cells. Fibroblasts and hematopoietic as well as tumor cells are an abundant source of angiogenic molecules such as VEGF family members (e.g., VEGF-A, VEGF-B, PlGF), FGF, and MMPs. As discussed in the text, there is significant debate in the field regarding the contribution of bone marrow-derived cells to the endothelial cell layer.
known to bind and regulate chemokines (Bandyopadhyay et al., 2006) . The authors provide evidence that DARC interacts with tumor cells via KAI1, a tetraspanin cell surface protein previously identified as a suppressor of prostate metastasis (Dong et al., 1995) . This interaction inhibits tumor cell proliferation and modulates the senescence genes TBX2 and p21. In vivo, the presence of KAI1 inhibited metastasis in wild-type, but not DARC-deficient, mice. These studies indicate that, in analogy to the developing embryo, endothelial cells can directly affect tumor cell biology.
Exploiting Angiogenic Mechanisms in Pathological Settings
Much effort has been invested in discovering the mechanistic basis of vascular growth and maintenance for the purpose of developing targets that limit angiogenesis. This strategy has produced promising therapies capable of treating cancer and angiogenic eye disease (Ferrara and Kerbel, 2005) . The first FDA-approved antiangiogenic agents (bevacizumab, pegaptanib, ranibizumab, sunitinib, and sorafenib) inhibit the activity of VEGF-A and potentially other members of the VEGF gene family such as placental growth factor (PlGF), VEGF-B, VEGF-C, and VEGF-D. Such drugs extend life expectancy in patients with certain malignancies when used in combination with chemotherapy (Ferrara and Kerbel, 2005) . Anti-VEGF therapy is also beneficial in treating the wet (neovascular) form of age-related macular degeneration (Brown et al., 2006; Gragoudas et al., 2004) .
Ongoing studies are aimed at further defining the reciprocal signals that function during interactions between the vasculature and its environment with the hope of identifying new targetable pathways. Indeed, inhibiting Notch activation in endothelial cells by blocking Delta-like 4 reduced tumor size in xenograft cancer models. Delta-like 4 inhibitors were additive with anti-VEGF treatments and, in some cases, were effective against select anti-VEGF-resistant tumors. Interestingly, these studies have helped define the effect of this molecule on endothelial cells at a mechanistic level, information important for processes that function during development. Delta-like 4 limits endothelial cell proliferation, favoring differentiation and maturation, while its blockade results in increased amounts of immature, nonfunctioning vessels (NogueraTroise et al., 2006; Ridgway et al., 2006) . Understanding interactions between endothelial and vascular support cells is also important. For example, in an animal model, inhibiting pericytes in addition to endothelial cells was considerably more efficacious in late-stage tumors than VEGF inhibition alone (Bergers et al., 2003) . These and other studies highlight the rapid advances occurring in the field and create enthusiasm for the future of antiangiogenic therapeutics.
Conclusions and Future Directions
There is much evidence that blood vessels are integral components of the developing embryo and that endothelial cells can supply inductive signals independent of the circulation. In addition, interactions between the vascular system and adult tissues are complex where the endothelial compartment supports tissue-specific functions and responds to specialization signals. The future challenge will be to continue identifying the molecular players mediating these activities. Such discoveries could lead to a better understanding of how to manipulate processes such as neural and hematopoietic stem cell growth or to induce successful therapeutic angiogenesis. Furthermore, we are only beginning to understand the cells and molecules involved in establishing vessel diversity, which could lead to the development of tissue-specific angiogenic modulators. In this review, we have focused on information concerning blood endothelial cells, but a second type, lymphatic endothelial cells, is also present within most tissues . Lymphatic endothelial cells could also supply signals that affect the surrounding microenvironment during normal and pathological conditions. Little is known about these potential mechanisms, but recent seminal advances in the lymphatic biology field have made identifying such activities possible. Future work will certainly elaborate on many of these issues, and the results are sure to uncover interesting and exciting information.
